Marie C Montás
Biographic Data
| ID | 9022838 |
|---|---|
| NAME | Marie C Montás |
| GIVEN NAMES | Marie C |
| FAMILY NAME | Montás |
| SIGNATURE | MONTÁS M C |
| AFFILIATIONS | Harvard Global Health Institute |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Excessive active pharmaceutical ingredients in substandard and falsified drugs should also raise concerns in low-income countries
Substandard and falsified (SF) medicines still do not receive enough attention in public health. Substandard medicines are authorised medical products that fail to meet their quality standards or specifications, or both, due to within-factory errors or degradation in supply chains. Falsified medicines, instead, are defined as deliberately and fraudulently misrepresenting medicines’ identity, composition, or source [...]
No prominent works on this page.
Excessive active pharmaceutical ingredients in substandard and falsified drugs should also raise concerns in low-income countries
Substandard and falsified (SF) medicines still do not receive enough attention in public health. Substandard medicines are authorised medical products that fail to meet their quality standards or specifications, or both, due to within-factory errors or degradation in supply chains. Falsified medicines, instead, are defined as deliberately and fraudulently misrepresenting medicines’ identity, composition, or source [...]
Active ingredient (1 works) · Business (1 works) · Environmental health (1 works) · Intellectual Property and Patents (1 works) · Medicine (1 works) · Pharmaceutical Economics and Policy (1 works) · Pharmaceutical Quality and Counterfeiting (1 works) · Pharmacology (1 works)